StockCall.com Provides Stock Research on Medtronic Inc., Herbalife Ltd., Orexigen Therapeutics Inc., and Novartis AG
New York City, New York -- (May 06, 2013)
The Affordable Care Act (ACA), which was upheld by the Supreme Court last year, is expected to result in higher costs for the healthcare industry. Although most of the players in the industry have supported ACA, medical appliances & equipment makers, on the other hand, have been critical about some aspects of the reform. One of the features of the ACA that medical appliances & equipment makers are opposing is the 2.3% tax on U.S. gross sales of medical devices. Device makers say that the tax will increase their costs and hurt innovation. Costs for other players in the healthcare industry such as drug manufacturers and biotechnology companies are also expected to rise; however, most companies expect to benefit from the reform in the long-term. The healthcare sector was among the major gainers in the S&P 500 on Friday, closing 0.58% higher. Among the major movers in the sector were Medtronic Inc. (NYSE: MDT), Herbalife Ltd. (NYSE: HLF), Orexigen Therapeutics Inc. (NASDAQ: OREX), and Novartis AG (NYSE: NVS). StockCall has released free charting and technical research on these aforementioned companies. Register to read these reports at
www.stockcall.com/report
Shares of Medtronic Inc. edged higher in Friday’s trading session, tracking gains in the broad market. The stock rose to an intra-day high of $47.97 before finishing the day 0.59% higher at $47.72 on volume of 3.49 million. Medtronic’s shares have gained more than 2.20% in the last three sessions. The stock is currently trading close to its 52-week high of $47.98. The company’s shares have outperformed the S&P 500 so far in 2013, gaining nearly 17%. Sign up for the free report on MDT at
www.StockCall.com/MDT050613.pdf
Shares of Herbalife Ltd. rose sharply in trading on Friday. The stock traded between $39.86 and $41.13 before finishing the day 3.14% higher at $41 on volume of 2.21 million. Herbalife’s shares have seen a series of highs over the last two weeks. The rally has helped the stock to break through $40 resistance level which is a bullish signal. The positive trend is further confirmed by the stock’s MACD chart. HLF free technical report can be accessed by signing up at
www.StockCall.com/HLF050613.pdf
Another major gainer in the healthcare sector on Friday was Orexigen Therapeutics Inc. Shares of the biotechnology company finished 1.15% higher at $6.14 on volume of 499,551. Orexigen’s shares have gained nearly 17% so far in 2013 as compared to a gain of nearly 13.20% for the S&P 500. Despite the gains, the stock is still trading more than 20.50% below its 52-week high. The company’s shares are currently trading above their 50-day and 200-day moving averages. Free report on OREX can be accessed by registering at
www.StockCall.com/OREX050613.pdf
Novartis AG shares fluctuated between gains and losses on Friday before finishing the day nearly flat. The stock closed 0.01% lower at $73.49 on above average volume of 1.65 million. Novartis’ shares touched an intraday high of $73.86 on Friday. The stock is currently trading more than 1% below its 52-week high. Shares of NVS have outperformed the S&P 500 thus far in 2013, gaining more than 20.50%. However, the stock’s MACD chart suggests that market sentiment is currently bearish.Register withStockCall and download the research on NVS for free at
www.StockCall.com/NVS050613.pdf
About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines. Sign up today to talk to our financial analyst at
www.stockcall.com
Contact Person:
William T. Knight
Email: info@stockcall.com
Contact Number: (646) 396-9857 (9:00 am EST – 01:30 pm EST)